AACR Special Conference in Cancer Research: Acute Lymphoblastic Leukemia
AACR Special Conference in Cancer Research: Acute Lymphoblastic Leukemia
Related Articles
Highlights from ASH 2024: Optimizing Frontline Therapy in Transplant-Eligible MM
Panelists discuss recent clinical trial findings, including the PERSEUS, CASSIOPEIA, IsKia, and GMMG-HD7 studies, and how these evolving treatment strategies are shaping the approach to…
Novel Anti-Estrogen Therapies Are Poised to Expand Treatment Options in Advanced ER+ Breast Cancer
Seth Wander, MD, PhD on novel anti-estrogen therapies that could expand treatment options in estrogen receptor–positive advanced breast cancer.
Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Research Grants, in Partnership with Pelotonia & AACR
$700,000 over three years for female associate professors performing research that has a direct applicability and relevance to the understanding, prevention, interception, early detection, diagnosis,…
ASH 2024: Multiple Myeloma Studies May Change Practice
Research presented at ASH 2024 could change the treatment of patients with newly diagnosed and relapsed or refractory MM, according to experts.
DARA + VRd in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Analysis of Minimal Residual Disease in the PERSEUS Trial
Hematologic oncology specialists review recent data from the PERSEUS trial analyzing minimal residual disease in patients with newly diagnosed multiple myeloma who receive DARA-VRd.
How Luspatercept Could Shake Up MDS Management—With Rory Shallis, MD
Dr Shallis discusses the ELEMENT-MDS trial in MDS and the potential of intervening with luspatercept before patients become RBC transfusion dependent.
FDA Approves Ensartinib in Metastatic ALK-Positive NSCLC
Data from the phase 3 eXalt3 trial support the approval of ensartinib in adult patients with metastatic ALK-positive non–small cell lung cancer.
FDA Approves Ensartinib in ALK-Positive NSCLC
The FDA has granted ensartinib approval for adult patients with ALK-positive non–small cell lung cancer.
Novel Study Reveals How Aging Immune System Fuels Cancer Growth, Potentially Opening New Avenues for Prevention
A novel study by researchers at the Icahn School of Medicine at Mount Sinai addresses a critical yet under-explored question in cancer research: Why is…
Congress: Pass an end-of-year bill that includes crucial provisions for blood cancer patients
Join me in calling your U.S. Representative to insist they pass a bill that includes vital provisions for blood cancer patients. Failure to do so…
